Immunomic Therapeutics signed a $315 million licensing deal with a Japanese pharmaceutical company last year.
Now the company is looking to help another Maryland biotech startup get off the ground.
The Rockville-based company is accepting applications for its Cancer Discovery Incubator through Dec. 31.
The award is offering a company a $10,000/month stipend, bench space and supplies to conduct proof-of-concept experiments. Immumonic leaders William Hearl and Teri Heiland will also provide mentorship. The company is partnering with BioHealth Innovation on the effort.
READ FULL ARTICLE HERE
